Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit
NCT ID: NCT01565915
Last Updated: 2013-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
221 participants
INTERVENTIONAL
2012-03-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Perlane-L
Perlane-L treatment
Perlane-L
Perlane-L Injection in the midface
Non-Treatment
Non-Treatment Arm
Non-treatment
Non-treatment Arm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Perlane-L
Perlane-L Injection in the midface
Non-treatment
Non-treatment Arm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Other items as identified in the protocol
Exclusion Criteria
* Other items as identified in the protocol
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medicis Global Service Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beverly Hills, California, United States
San Francisco, California, United States
Vista, California, United States
Aventura, Florida, United States
Coral Gables, Florida, United States
Chicago, Illinois, United States
Hunt Valley, Maryland, United States
Chestnut Hill, Massachusetts, United States
Mount Kisco, New York, United States
New York, New York, United States
Eugene, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MA-1400-05
Identifier Type: -
Identifier Source: org_study_id